Literature DB >> 11004419

Choice of effect measure for epidemiological data.

S D Walter1.   

Abstract

The debate concerning the choice of effect measure for epidemiologic data has been renewed in the literature, and it suggests some continuing disagreement between the pertinent clinical and statistical criteria. In this article, some defining characteristics of the main choices of effect measure [risk difference (RD), relative risk (RR), and odds ratio (OR)] for binary data are presented and compared, with consideration of both the clinical and statistical perspectives. Relationships of these measures to the relative risk reduction (RRR) and number needed to treat (NNT) are also discussed. A numerical comparison of models of constant RD, RR, and OR is made to assess when and by how much they might differ in practice. Typically the models show only small numerical differences, unless extreme extrapolation is involved. The RD and RR models can predict impossible event rates, either less than zero or greater than 100%. Each measure has potential theoretical justification. RD and RR may enjoy some advantages for communication of risk, but OR may be preferred for data analysis. A clear distinction should be maintained between the objectives of data analysis and subsequent risk communication, and different effect measures may be needed for each.

Mesh:

Year:  2000        PMID: 11004419     DOI: 10.1016/s0895-4356(00)00210-9

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  40 in total

1.  Prophylactic Ankle Taping and Bracing: A Numbers-Needed-to-Treat and Cost-Benefit Analysis.

Authors:  Lauren C. Olmsted; Luzita I. Vela; Craig R. Denegar; Jay Hertel
Journal:  J Athl Train       Date:  2004-03       Impact factor: 2.860

Review 2.  Communicating risks at the population level: application of population impact numbers.

Authors:  Richard F Heller; Iain Buchan; Richard Edwards; Georgios Lyratzopoulos; Patrick McElduff; Selwyn St Leger
Journal:  BMJ       Date:  2003-11-15

3.  Indirect comparisons of treatment effects in multiple sclerosis.

Authors:  Maria Pia Sormani; Alessio Signori
Journal:  Eur J Clin Pharmacol       Date:  2012-02-29       Impact factor: 2.953

Review 4.  Frequency of treatment-effect modification affecting indirect comparisons: a systematic review.

Authors:  Michael Coory; Susan Jordan
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

5.  Consistently estimating absolute risk difference when translating evidence to jurisdictions of interest.

Authors:  Simon Eckermann; Michael Coory; Andrew R Willan
Journal:  Pharmacoeconomics       Date:  2011-02       Impact factor: 4.981

6.  Bisphosphonates and risk of atrial fibrillation: a meta-analysis.

Authors:  Seo Young Kim; Min Jung Kim; Suzanne M Cadarette; Daniel H Solomon
Journal:  Arthritis Res Ther       Date:  2010-02-19       Impact factor: 5.156

7.  Risk of low birth weight associated with advanced maternal age among four ethnic groups in the United States.

Authors:  Babak Khoshnood; Stephen Wall; Kwang-sun Lee
Journal:  Matern Child Health J       Date:  2005-03

Review 8.  Combined radiochemotherapy in patients with locally advanced pancreatic cancer: a meta-analysis.

Authors:  Yue Chen; Xian-Jun Sun; Ting-Hui Jiang; Ai-Wu Mao
Journal:  World J Gastroenterol       Date:  2013-11-14       Impact factor: 5.742

9.  Prevalence of infection with herpes simplex virus types 1 and 2 in Australia: a nationwide population based survey.

Authors:  A L Cunningham; R Taylor; J Taylor; C Marks; J Shaw; A Mindel
Journal:  Sex Transm Infect       Date:  2006-04       Impact factor: 3.519

10.  Rank reversal in indirect comparisons.

Authors:  Edward C Norton; Morgen M Miller; Jason J Wang; Kasey Coyne; Lawrence C Kleinman
Journal:  Value Health       Date:  2012-09-07       Impact factor: 5.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.